SMS PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of SMS PHARMACEUTICALS have increased by 35.86% YoY .
The Earnings Per Share (EPS) of SMS PHARMACEUTICALS has increased by Positive YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SMS PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 532815|NSE : SMSPHARMA]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹709 Cr | ₹522 Cr | ₹520 Cr | ₹563 Cr | ₹412 Cr |
| Expenses | ₹593 Cr | ₹468 Cr | ₹405 Cr | ₹442 Cr | ₹332 Cr |
| Operating Profit (Excl OI) | ₹117 Cr | ₹55 Cr | ₹115 Cr | ₹121 Cr | ₹80 Cr |
| Other Income | ₹4.46 Cr | ₹4.91 Cr | ₹5.20 Cr | ₹3.45 Cr | ₹5.11 Cr |
| Interest | ₹24 Cr | ₹22 Cr | ₹19 Cr | ₹11 Cr | ₹12 Cr |
| Depreciation | ₹32 Cr | ₹32 Cr | ₹32 Cr | ₹22 Cr | ₹22 Cr |
| Profit Before Tax | ₹66 Cr | ₹5.35 Cr | ₹68 Cr | ₹91 Cr | ₹51 Cr |
| Profit After Tax | ₹49 Cr | ₹3.88 Cr | ₹68 Cr | ₹61 Cr | ₹33 Cr |
| Consolidated Net Profit | ₹50 Cr | ₹-7.06 Cr | ₹62 Cr | ₹63 Cr | ₹32 Cr |
| Earnings Per Share (Rs) | ₹5.89 | ₹-0.83 | ₹7.35 | ₹7.39 | ₹3.73 |
| PAT Margin (%) | 6.55 | 0.70 | 12.25 | 10.04 | 7.25 |
| ROE(%) | 10.16 | 0.83 | 15.41 | 16.07 | 9.76 |
| ROCE(%) | 11.73 | 3.79 | 12.60 | 17.62 | 13.06 |
| Total Debt/Equity(x) | 0.55 | 0.55 | 0.55 | 0.61 | 0.44 |
Key Financials |
||
| Market Cap | : | ₹ 1,799.9 Cr |
| Revenue (TTM) | : | ₹ 780.4 Cr |
| Net Profit(TTM) | : | ₹ 63.4 Cr |
| EPS (TTM) | : | ₹ 7.5 |
| P/E (TTM) | : | 28.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SMS PHARMACEUTICALS | -1.4% | -4.8% | 36.5% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.8% | -3.6% | 10.8% |
| CIPLA | -1.5% | 0.2% | 1.2% |
| DR REDDYS LABORATORIES | -1.6% | -9.2% | -4.3% |
| ZYDUS LIFESCIENCES | -7.4% | -5.1% | 9.9% |
| DIVIS LABORATORIES | -2.5% | 1.5% | 59.1% |
| MANKIND PHARMA | -2.3% | -6.7% | 11% |
| TORRENT PHARMACEUTICALS | -3.1% | -4.7% | 18.5% |
| LUPIN | -7.4% | -4.9% | 29.5% |
SMS PHARMACEUTICALS Revenues
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | 35.86 % |
| 5 Yr CAGR | 14.55 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹709 Cr | 35.86 | |
| Mar2023 | ₹522 Cr | 0.42 | |
| Mar2022 | ₹520 Cr | -7.69 | |
| Mar2021 | ₹563 Cr | 36.71 | |
| Mar2020 | ₹412 Cr | - | |
SMS PHARMACEUTICALS Operating Profit
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | 114.10 % |
| 5 Yr CAGR | 9.91 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹117 Cr | 114.10 | |
| Mar2023 | ₹55 Cr | -52.42 | |
| Mar2022 | ₹115 Cr | -5.38 | |
| Mar2021 | ₹121 Cr | 51.38 | |
| Mar2020 | ₹80 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 57.51 % |
| 5 Yr CAGR | -4.06 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 16.46% | 57.51 | |
| Mar2023 | 10.45% | -52.61 | |
| Mar2022 | 22.05% | 2.51 | |
| Mar2021 | 21.51% | 10.71 | |
| Mar2020 | 19.43% | - | |
SMS PHARMACEUTICALS Profit After Tax
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | Positive |
| 5 Yr CAGR | 12.08 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹50 Cr | Positive | |
| Mar2023 | ₹-7.06 Cr | Negative | |
| Mar2022 | ₹62 Cr | -0.49 | |
| Mar2021 | ₹63 Cr | 98.03 | |
| Mar2020 | ₹32 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 835.71 % |
| 5 Yr CAGR | -2.51 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 6.55 % | 835.71 | |
| Mar2023 | 0.7 % | -94.29 | |
| Mar2022 | 12.25 % | 22.01 | |
| Mar2021 | 10.04 % | 38.48 | |
| Mar2020 | 7.25 % | - | |
SMS PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | Positive |
| 5 Yr CAGR | 12.10 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.89 | Positive | |
| Mar2023 | ₹-0.83 | Negative | |
| Mar2022 | ₹7.35 | -0.54 | |
| Mar2021 | ₹7.39 | 98.12 | |
| Mar2020 | ₹3.73 | - | |
SMS PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 532815|NSE : SMSPHARMA]
| Y-o-Y | 209.50 % |
| 5 Yr CAGR | -2.65 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 11.73% | 209.50 | |
| Mar2023 | 3.79% | -69.92 | |
| Mar2022 | 12.6% | -28.49 | |
| Mar2021 | 17.62% | 34.92 | |
| Mar2020 | 13.06% | - | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹212.5 |
| Current MarketCap | : | ₹ 1,799.9 Cr |
| Updated EOD on | : | Feb 12,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -1.4% |
-4.8% |
36.5% |
| SENSEX | -2.7% |
-0.4% |
6.4% |
SMS PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE ALLCAP | -3.7% | -1.7% | 4.4% |
| S&P BSE HEALTHCARE | -5.2% | -5.1% | 16.9% |
| S&P BSE MIDSMALLCAP | -6.4% | -7.1% | 3.2% |
| S&P BSE SMALL CAP | -6.7% | -8.3% | 3.3% |
No NSE index found
You may also like the below Video Courses
FAQ about SMS PHARMACEUTICALS Financials
How the annual revenues of SMS PHARMACEUTICALS have changed ?
The Revenues of SMS PHARMACEUTICALS have increased by 35.86% YoY .
How the Earnings per Share (EPS) of SMS PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SMS PHARMACEUTICALS has increased by Positive YoY .
Check out Intrinsic Value of Peers of SMS PHARMACEUTICALS
Compare Stock Analytics of Peers of SMS PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
